跳至主要内容
临床试验/NCT06569121
NCT06569121招募中不适用

Efficacy of an Evidence-based Telehealth-delivered Weight-loss Intervention to Enhance Access and Reach Underserved Groups After Stroke

Baylor Research Institute2 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2024年12月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
94
试验地点
2
主要终点
Body Weight

研究概览

简要总结

Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body Mass Index ≥25
  • All types of stroke
  • Able to Participate in Physical Activity
  • ≥12 months post first stroke
  • Have internet, phone, or computer access, or be willing to use one provided by the study team

排除标准

  • Contraindications for physical activity
  • Low Cognitive Function
  • Residing in hospital, acute rehab, skilled nursing facility
  • Not fluent in the English language
  • Pre-existing eating disorder
  • Pregnancy

结局指标

主要结局

Body Weight

时间窗: Baseline, 3, 6, 9, 12, 18 month

Body weight (lbs) will be captured via self-weighing using provided BodyTrace Smart Scale, which includes cellular connectivity so weight will be sent directly to the research team. The scales have demonstrated good concordance rates with self-weighing in previous research. Scales will be setup by the research team before being mailed to participants with instructions.

次要结局

  • Blood Glucose(Baseline, 3, 6, 9, 12, 18 month)
  • Circumference(Baseline, 3, 6, 9, 12, 18 month)
  • Height(Baseline, 3, 6, 9, 12, 18 month)
  • Body Mass Index (BMI)(Baseline, 3, 6, 9, 12, 18 month)
  • Blood pressure(Baseline, 3, 6, 9, 12, 18 month)
  • Blood Sugar, Hemoglobin A1c (HbA1c)(Baseline, 3, 6, 9, 12, 18 month)
  • High Density Lipoprotein (HDL) cholesterol(Baseline, 3, 6, 9, 12, 18 month)
  • Low Density Lipoprotein (LDL) cholesterol(Baseline, 3, 6, 9, 12, 18 month)
  • Fasting venous sample(Baseline, 3, 6, 9, 12, 18 month)
  • 8-year Diabetes Risk(Baseline, 3, 6, 9, 12, 18 month)
  • Metabolic Syndrome Severity Score(Baseline, 3, 6, 9, 12, 18 month)
  • Behavioral Risk Factor Surveillance System (BRFSS)(Baseline, 3, 6, 9, 12, 18 month)
  • Substance Use(Baseline, 12, 18 month)
  • Neighborhood Environment Walkability Scale (NEWS)(Baseline, 3, 6, 9, 12, 18 month)
  • Social Support for Healthy Eating (SSEH)(Baseline, 3, 6, 9, 12, 18 month)
  • Quality of Life(Baseline, 3, 6, 9, 12, 18 month)
  • Self-Rated Abilities for Health Practice(Baseline, 3, 6, 9, 12, 18 month)
  • Social Support for Physical Activity (SSPA)(Baseline, 3, 6, 9, 12, 18 month)
  • Care Partner Healthy Lifestyle Support Tool(Baseline, 3, 6, 9, 12, 18 month)
  • Telehealth Usability and Satisfaction(6, 12, 18 month)
  • Exit Survey & Interview(12 or 18 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验